Continuous Versus On Demand Treatment with Cetirizine for Allergic Rhinitis (Q39451481)

12 September 2017

title

Continuous versus on demand treatment with cetirizine for allergic rhinitis (English)

1 reference

12 September 2017

Continuous Versus On Demand Treatment with Cetirizine for Allergic Rhinitis (English)

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

2 December 2024

1

G. Ciprandi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9433365

2 December 2024

Giorgio Walter Canonica

5

object named as

G. W. Canonica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9433365

2 December 2024

author name string

G. Passalacqua

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9433365

2 December 2024

M. Mincarini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9433365

2 December 2024

V. Ricca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9433365

2 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9433365

2 December 2024

publication date

1 December 1997

1 reference

12 September 2017

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9433365

full work available at URL

2 December 2024

https://api.elsevier.com/content/article/PII:S1081120610630578?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

https://api.elsevier.com/content/article/PII:S1081120610630578?httpAccept=text/plain

2 December 2024

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

Annals of Allergy, Asthma & Immunology

2 December 2024

published in

1 reference

12 September 2017

volume

79

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

507-511

1 reference

Mucosal inflammation in asthma

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Challenge tests in nose and bronchi: pharmacological modulation of rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Seasonal rhinitis and azelastine: long- or short-term treatment?

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

The role of adhesion molecules in human eosinophil and basophil recruitment

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

A possible role for adhesion molecules in asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Adhesion molecules of allergic inflammation: recent insights into their functional roles.

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influx

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63057-8

7 January 2021

Identifiers

1 reference

12 September 2017

1 reference